Criterion and Construct Validity of the Pocket-Worn RISE Device to Assess Movement Behaviour in Community-Dwelling People with Stroke. [PDF]
Biemans CFM +6 more
europepmc +1 more source
Genetic contribution to severe COVID-19 in adults under 60 years without major comorbidities in the German National Pandemic Cohort Network (NAPKON). [PDF]
Abolhassani A +46 more
europepmc +1 more source
Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database. [PDF]
Shirani A, Cross AH, Stuve O.
europepmc +1 more source
Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA). [PDF]
Krueger K +10 more
europepmc +1 more source
Benzodiazepine receptor agonists in hospitalised patients in the Netherlands: initiation, continuation and discontinuation - a retrospective observational analysis. [PDF]
de Gans CJ +6 more
europepmc +1 more source
Thigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With HIV-1: A Substudy of the Phase 3b ATLAS-2M Study. [PDF]
Ford SL +16 more
europepmc +1 more source
Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example. [PDF]
Bots SH +22 more
europepmc +1 more source
SUNRISE-CRC: a randomized phase II study of high-dose intermittent sunitinib versus trifluridine/tipiracil in metastatic colorectal carcinoma. [PDF]
Janssen JBE +17 more
europepmc +1 more source
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial. [PDF]
Mai EK +38 more
europepmc +1 more source
Correlation of surgical volume in gynecological cancer centers with the quality of ovarian cancer care. [PDF]
Ortmann O +8 more
europepmc +1 more source

